Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI
Alex ZhavoronkovDedicated to extending healthy productive life for everyone on the planet. Covers advances in longevity, AI, robotics, cryonics, quantum, and other emerging technologies. Posts are strictly personal, not reflective of positions of Insilico Medicine.
| Platform |  | Pricing | Only free issues | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 16 | Founded | 2 years ago | Last Issue | 4 months ago |
| Active | |||||
Read this Newsletter
forever.aiLatest Issues
The Next Battlefield in Frontier AI Will Be in AI for Science
The era of Generative AI has brought us miracles in language, coding, and image generation. We have grown accustomed to Large Language Models (LLMs) that can write sonnets in the style of Shakespeare or debug complex Python scripts in secon...
Pharma, Biotechnology, and Longevity: 2025 Year in Review
Precision Interventions & Small Molecule Renaissance
The year 2025 in biopharma was marked by precision breakthroughs across pharmaceuticals, biotechnology, and longevity research. The FDA approved 55 new drugs (46 novel drug entities)...
Woke Longevity: How the Healthspan vs. Lifespan Debate Masks Real Problems
Thanks for reading Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI! Subscribe for free to receive new posts and support my work.
As world leaders gather in Davos and many of my friends in aging research organize side events on...
Longevity Couture: Can we Make Longevity Clothing Fashionable?
About three weeks ago, I walked the streets of Milan—the undisputed capital of global fashion—with a high-level business delegation from Hong Kong, the undisputed capital of longevity.
Thanks for reading Forever.AI: AI, Robotics, Quantum,...
The "Swiss Army Knife" Longevity Target NLRP3 Strikes Again
In a previous post on Forever.ai titled “Beyond GLP-1: Is NLRP3 the Next Trillion Dollar Target?”, I argued that the NLRP3 inflammasome was the next trillion-dollar target, a “master switch” for the chronic, low-grade inflammation—or “infla...
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI.
| Subscribers | Engagement | 76 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Alex Zhavoronkov, PhD, is CEO of Insilico Medicine, a generative AI biotech, which raised $500mil, nominated 22 preclinical candidates and got into clinical trials. He's also an adjunct professor at the Buck Institute for Aging.
Frequently Asked Questions
How can I access the email archive for this newsletter?
You can find recent issues that have been published by this newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does this newsletter have?
To see how many people subscribe to this newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in this newsletter?
Newsletter advertising can be extremely effective when it's done right. Before you pitch this newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like this newsletter?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact this newsletter using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to this newsletter?
Scroll up to where it says Related Newsletters to see other publications like this newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact this newsletter?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.